Clinical Trials

13 enrolled

Liver Neoplasms

NCT05582018 2025-09-15

PANORAMA

4 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT04502082 2025-09-08

Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1)

8 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00051532 2025-02-25

Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma

700 enrolled

Carcinoma, Liver Neoplasms, Neoplasms

NCT00051545 2025-02-25

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

608 enrolled

Carcinoma, Liver Neoplasms, Neoplasms

NCT05497453 2025-02-03

MYCHELANGELO I

Phase 1/2 Terminated

24 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03685591 2024-06-26

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryOther solid neoplasmThoracic

49 enrolled 33 charts

Adenocarcinoma, Breast Neoplasms, Carcinoma, Renal Cell, Camurati-Engelmann Syndrome, Liver Neoplasms, Melanoma, Mesothelioma, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Neoplasms, Squamous Cell

NCT05061537 2024-04-12

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

13 enrolled 16 charts

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Liver Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms

NCT03753789 2024-01-05

Ablation Confirmation Study

46 enrolled 14 charts

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Liver Neoplasms

NCT05363605 2023-12-19

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

Phase 1/2 Terminated

6 enrolled

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT04311710 2023-02-24

CheckMate 76U

DermatologicGastrointestinalGenitourinaryThoracic

21 enrolled

Urinary Bladder Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Skin Neoplasms

NCT01464593 2022-10-13

ABLATE

2 enrolled 5 charts

Colonic Neoplasms, Liver Neoplasms

NCT03998033 2022-08-23

ET-109

2 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01402908 2022-06-23

PATRON

520 enrolled 27 charts

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

NCT02721056 2021-05-10

NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers

Phase 1/2 Terminated

23 enrolled

Liver Neoplasms

NCT04264754 2021-05-06

Characterization of Methylation Patterns in Hepatocellular Carcinoma

120 enrolled

Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms

NCT03516695 2021-04-21

READ90Y

95 enrolled

Liver Neoplasms

NCT00503867 2020-12-10

SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma

10 enrolled 12 charts

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03644511 2020-08-21

SORAGO-HCC

3 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03349255 2019-07-01

Clinical Study of ET1402L1-CAR T Cells in AFP Expressing Hepatocellular Carcinoma

3 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02690350 2018-05-16

An Open Study Assessing the Safety and Tolerability of U3-1784

10 enrolled

Liver Neoplasms

NCT01668017 2017-08-23

A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy

26 enrolled 44 charts

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02323906 2017-03-20

Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer

12 enrolled

GastrointestinalGenitourinaryThoracic

Carcinoma, Carcinoma, Hepatocellular, Liver Neoplasms

NCT00332280 2013-03-20

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

Phase 2/3 Terminated

67 enrolled

Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Genital Neoplasms, Female, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

NCT00405873 2013-03-20

Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003

73 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01009593 2012-09-10

Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

1,035 enrolled

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT01238653 2012-08-08

Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures

8 enrolled

Liver Neoplasms, Neoplasms

NCT00568308 2011-06-15

PATHWAY

600 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

NCT00106054 2010-08-27

Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases

2 enrolled

Liver Neoplasms, Colorectal Neoplasms

NCT00034333 2005-06-24

Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer

Phase 2/3 Terminated

240 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00057382 2005-06-24

T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients

Phase 2/3 Terminated

750 enrolled